药监局严打中药饮片染色

2014-08-05 佚名 CFDA

日前,国家食品药品监督管理总局组织开展了中药饮片违法染色问题专项抽验。 按照药品“两打两建”专项行动工作部署,总局组织对安徽、甘肃、广东和四川4个省相关单位生产、经营或使用的部分中药饮品进行了抽样。专项抽验共抽样397批,检验证实22批存在染色问题,共涉及红花、延胡索、西红花3个品种。为保护公众用药安全,现将存在染色问题的中药饮片及相关生产、经营和使用单位予以曝光。 对中药饮片进行染色危害公

日前,国家食品药品监督管理总局组织开展了中药饮片违法染色问题专项抽验。

按照药品“两打两建”专项行动工作部署,总局组织对安徽、甘肃、广东和四川4个省相关单位生产、经营或使用的部分中药饮品进行了抽样。专项抽验共抽样397批,检验证实22批存在染色问题,共涉及红花、延胡索、西红花3个品种。为保护公众用药安全,现将存在染色问题的中药饮片及相关生产、经营和使用单位予以曝光。

对中药饮片进行染色危害公众用药安全,欺骗消费者,是严重的违法行为。总局已责成相关省(区、市)食品药品监督管理局对抽验证实存在染色问题的中药饮片及相关单位依法查处。

不符合标准规定的中药饮片名单

检品名称

批号

检品来源

检出色素或染料名称

红花

20120401

甘肃博慈药业科技有限责任公司

金橙Ⅱ、日落黄、柠檬黄、胭脂红

红花

20100701

甘肃省定西市安定区玉顺堂药品经营店

金橙Ⅱ、日落黄、柠檬黄、胭脂红

红花

121108

甘肃省兰州市城关区渭源路街道南河新村社区卫生服务站

金橙Ⅱ、酸性红74、柠檬黄

红花

130401

东莞市中药饮片有限公司

金橙Ⅱ、胭脂红

红花

120801

东莞市中医院

金橙Ⅱ

121101

金橙Ⅱ、胭脂红

红花

121101

广东万寿堂医药连锁有限公司

金橙Ⅱ、柠檬黄、胭脂红

红花

130201

深圳市亚洲大药房连锁有限公司笋岗药店

金橙Ⅱ

130601

胭脂红

130410

金橙Ⅱ、胭脂红

红花

20130501

深圳市友和医药大药房连锁有限公司福华药店

金橙Ⅱ

红花

130502

深圳市中医院

金橙Ⅱ、胭脂红

西红花

1109021

甘肃众友健康医药连锁有限公司众友药城

金胺O、胭脂红

延胡索

20130201

亳州市药材总公司三和堂药店

金胺O

延胡索

121116

淮南市第一人民医院

金胺O

延胡索

110901

甘肃省定西德生堂医药连锁有限责任公司东方解放桥超市

金胺O

延胡索

120204

甘肃省定西市安定区玉顺堂药品经营店

金胺O

延胡索

130201

甘肃至仁同济大药房连锁有限公司二十九分店

金胺O

延胡索

121101

电白县清源中药饮片有限公司

金胺O

延胡索

130301

深圳市中医院

金胺O

130502

延胡索

121101

宜宾市第二中医院(宜宾市翠屏区中医医院)

金胺O

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=27347, encodeId=825e2e34768, content=药品安全很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Fri Jun 12 19:33:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27348, encodeId=c1632e348c0, content=需要治理, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Fri Jun 12 19:33:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301540, encodeId=36151301540ed, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Thu Aug 07 00:14:00 CST 2014, time=2014-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476465, encodeId=319414e6465ef, content=<a href='/topic/show?id=e50422525f6' target=_blank style='color:#2F92EE;'>#中药饮片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22525, encryptionId=e50422525f6, topicName=中药饮片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e11d7287409, createdName=xiay994455, createdTime=Thu Aug 07 00:14:00 CST 2014, time=2014-08-07, status=1, ipAttribution=)]
    2015-06-12 18619c0a62m

    药品安全很重要

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=27347, encodeId=825e2e34768, content=药品安全很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Fri Jun 12 19:33:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27348, encodeId=c1632e348c0, content=需要治理, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Fri Jun 12 19:33:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301540, encodeId=36151301540ed, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Thu Aug 07 00:14:00 CST 2014, time=2014-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476465, encodeId=319414e6465ef, content=<a href='/topic/show?id=e50422525f6' target=_blank style='color:#2F92EE;'>#中药饮片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22525, encryptionId=e50422525f6, topicName=中药饮片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e11d7287409, createdName=xiay994455, createdTime=Thu Aug 07 00:14:00 CST 2014, time=2014-08-07, status=1, ipAttribution=)]
    2015-06-12 18619c0a62m

    需要治理

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=27347, encodeId=825e2e34768, content=药品安全很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Fri Jun 12 19:33:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27348, encodeId=c1632e348c0, content=需要治理, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Fri Jun 12 19:33:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301540, encodeId=36151301540ed, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Thu Aug 07 00:14:00 CST 2014, time=2014-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476465, encodeId=319414e6465ef, content=<a href='/topic/show?id=e50422525f6' target=_blank style='color:#2F92EE;'>#中药饮片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22525, encryptionId=e50422525f6, topicName=中药饮片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e11d7287409, createdName=xiay994455, createdTime=Thu Aug 07 00:14:00 CST 2014, time=2014-08-07, status=1, ipAttribution=)]
    2014-08-07 xuyu
  4. [GetPortalCommentsPageByObjectIdResponse(id=27347, encodeId=825e2e34768, content=药品安全很重要, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Fri Jun 12 19:33:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=27348, encodeId=c1632e348c0, content=需要治理, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12a31627589, createdName=18619c0a62m, createdTime=Fri Jun 12 19:33:00 CST 2015, time=2015-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301540, encodeId=36151301540ed, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87935, encryptionId=2ba78e935dc, topicName=药监局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f5b299, createdName=xuyu, createdTime=Thu Aug 07 00:14:00 CST 2014, time=2014-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476465, encodeId=319414e6465ef, content=<a href='/topic/show?id=e50422525f6' target=_blank style='color:#2F92EE;'>#中药饮片#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22525, encryptionId=e50422525f6, topicName=中药饮片)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e11d7287409, createdName=xiay994455, createdTime=Thu Aug 07 00:14:00 CST 2014, time=2014-08-07, status=1, ipAttribution=)]